BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,090 filers reported holding BAXTER INTL INC in Q2 2021. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $20,502 | +12.3% | 450 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $18,252 | -20.4% | 450 | 0.0% | 0.01% | -20.0% |
| Q4 2022 | $22,937 | -4.4% | 450 | 0.0% | 0.01% | -9.1% |
| Q3 2022 | $24,000 | -17.2% | 450 | 0.0% | 0.01% | -8.3% |
| Q2 2022 | $29,000 | -66.7% | 450 | -60.0% | 0.01% | -61.3% |
| Q1 2022 | $87,000 | -10.3% | 1,125 | 0.0% | 0.03% | 0.0% |
| Q4 2021 | $97,000 | +7.8% | 1,125 | 0.0% | 0.03% | +3.3% |
| Q3 2021 | $90,000 | -1.1% | 1,125 | 0.0% | 0.03% | -3.2% |
| Q2 2021 | $91,000 | -27.2% | 1,125 | -27.6% | 0.03% | -31.1% |
| Q4 2020 | $125,000 | 0.0% | 1,553 | 0.0% | 0.04% | -11.8% |
| Q3 2020 | $125,000 | -6.7% | 1,553 | 0.0% | 0.05% | -12.1% |
| Q2 2020 | $134,000 | -5.6% | 1,553 | -11.4% | 0.06% | -13.4% |
| Q1 2020 | $142,000 | -44.7% | 1,753 | -43.0% | 0.07% | -17.3% |
| Q4 2019 | $257,000 | -4.5% | 3,078 | 0.0% | 0.08% | -9.0% |
| Q3 2019 | $269,000 | -2.5% | 3,078 | -8.6% | 0.09% | -11.0% |
| Q2 2019 | $276,000 | -4.8% | 3,367 | -5.6% | 0.10% | -14.5% |
| Q1 2019 | $290,000 | +23.4% | 3,567 | 0.0% | 0.12% | +14.7% |
| Q4 2018 | $235,000 | -5.2% | 3,567 | +10.9% | 0.10% | +3.0% |
| Q3 2018 | $248,000 | +4.2% | 3,217 | 0.0% | 0.10% | 0.0% |
| Q2 2018 | $238,000 | +13.9% | 3,217 | 0.0% | 0.10% | +12.5% |
| Q1 2018 | $209,000 | +154.9% | 3,217 | +103.9% | 0.09% | +151.4% |
| Q1 2017 | $82,000 | -9.9% | 1,578 | -17.6% | 0.04% | -12.5% |
| Q3 2016 | $91,000 | +4.6% | 1,915 | 0.0% | 0.04% | +8.1% |
| Q2 2016 | $87,000 | 0.0% | 1,915 | -5.9% | 0.04% | -5.1% |
| Q1 2016 | $87,000 | -66.4% | 2,035 | -71.3% | 0.04% | -69.5% |
| Q4 2015 | $259,000 | -32.2% | 7,085 | -30.9% | 0.13% | -28.9% |
| Q3 2015 | $382,000 | -87.3% | 10,255 | -76.1% | 0.18% | -86.9% |
| Q2 2015 | $3,002,000 | -30.2% | 42,925 | -31.7% | 1.38% | -25.3% |
| Q1 2015 | $4,303,000 | -6.8% | 62,817 | -0.3% | 1.84% | -11.0% |
| Q4 2014 | $4,617,000 | +1.6% | 62,994 | -0.6% | 2.07% | -5.0% |
| Q3 2014 | $4,546,000 | +16.8% | 63,344 | +17.7% | 2.18% | +13.5% |
| Q2 2014 | $3,892,000 | -1.6% | 53,830 | +0.2% | 1.92% | -6.0% |
| Q1 2014 | $3,955,000 | +16.5% | 53,745 | +10.1% | 2.04% | +12.5% |
| Q4 2013 | $3,395,000 | +17.8% | 48,815 | +11.3% | 1.82% | +16.4% |
| Q3 2013 | $2,882,000 | +7.6% | 43,875 | +13.4% | 1.56% | +2.0% |
| Q2 2013 | $2,679,000 | – | 38,680 | – | 1.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |